SS-31 Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use SS-31 report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Adverse reactions from the FDA label come first, then side effects reported in individual studies. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Any local administration reaction | 12 of 12 (100%) on elamipretide vs 8 of 12 (67%) on placebo | FDA label | FDA label (Forzinity) |
| Injection site erythema | 12 of 12 (100%) vs 3 of 12 (25%) on placebo | FDA label | FDA label (Forzinity) |
| Injection site pain | 9 of 12 (75%) vs 5 of 12 (42%) on placebo | FDA label | FDA label (Forzinity) |
| Injection site induration | 8 of 12 (67%) vs 2 of 12 (17%) on placebo | FDA label | FDA label (Forzinity) |
| Eosinophilia“Increases in absolute eosinophil counts were noted frequently in studies where duration of administration of FORZINITY was 30 days or greater.” | Frequency not stated | FDA label | FDA label (Forzinity) |
| Hypersensitivity reactions“Hypersensitivity reactions, including serious allergic reactions requiring emergency medical intervention, have been reported in patients receiving FORZINITY.” | Frequency not stated | FDA label | FDA label (Forzinity) |
| Injection site pruritus | 8 of 12 (67%) vs 2 of 12 (17%) on placebo | FDA label | FDA label (Forzinity) |
| Injection site bruising | 3 of 12 (25%) vs none on placebo | FDA label | FDA label (Forzinity) |
| Injection site urticaria | 3 of 12 (25%) vs none on placebo | FDA label | FDA label (Forzinity) |
| Injection site hemorrhage | none on elamipretide vs 1 of 12 (8%) on placebo | FDA label | FDA label (Forzinity) |
| Injection site reactions | 86% vs 71% placebo | Human RCTn = 176 | Ophthalmology science 2025, PMID 39605874 |
| Injection site pruritus | 46 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site pain | 33 of 117 on elamipretide; 6 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site erythema | 22 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site haemorrhage | 17 of 117 on elamipretide; 4 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site induration | 16 of 117 on elamipretide; 3 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site mass | 13 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site swelling | 11 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Eosinophil count increased | 7 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Hypertension | 5 of 117 on elamipretide; 0 of 59 on placebo | Human RCTn = 176 | ClinicalTrials.gov NCT03891875 |
| Injection site erythema | 94 of 109 on elamipretide (24-week double-blind period); 31 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Injection site pruritus | 82 of 109 on elamipretide (24-week double-blind period); 10 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Injection site pain | 43 of 109 on elamipretide (24-week double-blind period); 20 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Injection site swelling | 42 of 109 on elamipretide (24-week double-blind period); 7 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Injection site induration | 31 of 109 on elamipretide (24-week double-blind period); 6 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Eosinophil count increased | 7 of 109 on elamipretide (24-week double-blind period); 0 of 109 on placebo | Human RCTn = 218 | ClinicalTrials.gov NCT03323749 |
| Injection site reactions | 80% | Human RCTn = 30 | Journal of cachexia, sarcopenia and muscle 2020, PMID 32096613 |
| Injection site reactions | most common events; all participants had 1 or more mild or moderate adverse events | Human uncontrolled trialn = 21 | Ophthalmology science 2022, PMID 36246187 |
| Transient visual impairment | 1 participant withdrew | Human uncontrolled trialn = 21 | Ophthalmology science 2022, PMID 36246187 |
| Intolerable injection site reaction | 1 participant exited the study | Human uncontrolled trialn = 19 | Ophthalmology science 2022, PMID 36246181 |
| Conversion to neovascular AMD | 1 participant exited the study | Human uncontrolled trialn = 19 | Ophthalmology science 2022, PMID 36246181 |
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Most adverse events mild to moderate | most | Human RCTn = 218 | Neurology 2023, PMID 37268435 |
| No serious adverse events | none | Human RCTn = 36 | Circulation. Heart failure 2017, PMID 29217757 |
| Injection-site reactions | most common | Human uncontrolled trialn = 10 | Genetics in medicine 2024, PMID 38602181 |
What users report
Side effects people describe from their own use of SS-31, quoted from 28 Reddit threads we read in r/Peptides and r/Retatrutide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Tiredness or lethargy | 8 | “have the most strange severe fatigue. Ive been falling asleep all the time” r/Peptides, Mar 2026“it makes me super tired when I take it” r/Peptides, Jul 2025 |
| Dizziness | 2 | “I feel kind of dizzy” r/Peptides, Jul 2025“After taking I find myself getting dizzy when standing up too quick.” r/Peptides, Jun 2026 |
| Restlessness or feeling wired | 2 | “that had me wired the entire day and I couldn't sleep at night” r/Peptides, Apr 2026“I feel a bit of restlessness” r/Peptides, Mar 2026 |
| Trouble sleeping | 1 | “I couldn't sleep at night” r/Peptides, Apr 2026 |
| Higher resting heart rate | 1 | “when I took SS-31 it greatly increased my resting heart rate” r/Peptides, Apr 2026 |
| Headache | 1 | “gives me a mild headache post injection” r/Retatrutide, Mar 2025 |
| Itching after injection | 1 | “it being itchy after I pin” r/Peptides, Mar 2026 |
| Achy legs | 1 | “weird warm achey legs” r/Peptides, Mar 2026 |
| Diarrhea | 1 | “I have had diarrhea like crazy” r/Peptides, Aug 2024Also taking other compounds |
| Coughing up mucus | 1 | “coughing up all kinds of disgustingness” r/Peptides, Aug 2024Also taking other compounds |
| Hives or severe allergic reaction | 1 | “Got hives all over the place.” r/Peptides, Feb 2026Also taking other compounds |
| Numbness or tingling | 1 | “my entire body got jittery and numb” r/Peptides, Feb 2026Also taking other compounds |
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How SS-31 interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
What the Forzinity label warns about
The Forzinity label's contraindication is serious hypersensitivity to elamipretide or any of the excipients in Forzinity.[1]
The label says hypersensitivity has included rash and respiratory symptoms.[1]
The label also warns of benzyl alcohol toxicity and says not to use Forzinity in neonates.[1]
The most common adverse reactions are at the injection site.[1]
Injection-site reactions in the trials
In a crossover trial in adults with mitochondrial myopathy, injection site reactions were the most commonly reported adverse events (80%), most of them mild.[4]
In an age-related macular degeneration trial, adverse events were more common on elamipretide than placebo, mainly at the injection site.[2]
In the larger mitochondrial myopathy trial, most events were mild to moderate.[3]
An early randomized, placebo-controlled heart-failure trial of elamipretide reported no serious adverse events.[5]
Common questions
What are the side effects of SS-31?
The FDA label lists any local administration reaction, injection site erythema, injection site pain among others. The table on this page gives how often each happened and links each source.
What side effects do people who use SS-31 report?
In the 28 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (8 people), dizziness (2 people), restlessness or feeling wired (2 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is SS-31 safe?
The Forzinity label lists a hypersensitivity contraindication and warns of benzyl alcohol toxicity, saying not to use it in neonates.[1]
What are the side effects of elamipretide?
Injection-site reactions are the most common, in both the label and long-term Barth syndrome follow-up.[6]
More on SS-31
Sources
- 1FORZINITY (ELAMIPRETIDE HYDROCHLORIDE) INJECTION [STEALTH BIOTHERAPEUTICS INC.]FDA label (Forzinity), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 2ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation.Ophthalmology science · 2025PMID 39605874Accessed 2 Oct 2026
- 3Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.Neurology · 2023PMID 37268435Accessed 2 Oct 2026
- 4A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy.Journal of cachexia, sarcopenia and muscle · 2020PMID 32096613Accessed 2 Oct 2026
- 5Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.Circulation. Heart failure · 2017PMID 29217757Accessed 2 Oct 2026
- 6Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.Genetics in medicine : official journal of the American College of Medical Genetics · 2024PMID 38602181Accessed 2 Oct 2026
- 7A Phase 2 Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Elamipretide in Subjects With Age-Related Macular Degeneration With Non-central Geographic AtrophyClinicalTrials.gov (U.S. National Library of Medicine) · 2019clinicaltrials.govAccessed 11 Oct 2026
- 8A Phase 3 Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Treatment ExtensionClinicalTrials.gov (U.S. National Library of Medicine) · 2017clinicaltrials.govAccessed 11 Oct 2026
- 9Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.Ophthalmology science · 2022PMID 36246187Accessed 11 Oct 2026
- 10Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.Ophthalmology science · 2022PMID 36246181Accessed 11 Oct 2026
- 11Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 12Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 13Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 14Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 15Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 16Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 17Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 18Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 19Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
Found an error? Report a correction.